The CLTP001A12202 study will explore the safety, tolerability, and pharmacokinetics of LTP001 in healthy volunteers (Part A) and will evaluate the safety and efficacy (Part B) followed by safety extension in participants with pulmonary arterial hypertension.
A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallelgroup Study of Efficacy and Safety of Treprostinil Palmitil Inhalation Powder inParticipants with Idiopathic Pulmonary Fibrosis (IPF) – PALM-IPF
An Open-label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
A randomized, double-blinded, placebo-controlled, multinational, phase 3 study of the efficacy and safety of inhaled Treprostinil in subjects with progressive pulmonary fibrosis
